Single-cell immune checkpoint landscape of PBMCs stimulated with Candida albicans

References

• Lindberg E, Hammarström H, Ataollahy N, et al. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Sci Rep. 2019;9:1–6.
   Web of Science ®Google Scholar
• Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110–1122.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Orsetti E, Mazzanti S, et al. Candidemia in the elderly: what does it change? PLoS One. 2017;12:e0176576.
   PubMed Web of Science ®Google Scholar
• Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492–499.
   PubMed Web of Science ®Google Scholar
• Wykes MN, Lewin SR. Immune checkpoint blockade in infectious diseases. Nat Rev Immunol. 2018;18:91.
   PubMed Web of Science ®Google Scholar
• Chen Q, Xia R, Zheng W, et al. Metronomic paclitaxel improves the efficacy of PD-1 monoclonal antibodies in breast cancer by transforming the tumor immune microenvironment. Am J Transl Res. 2020;12:519.
   Web of Science ®Google Scholar
• Cruz E, Kayser V. Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy. Biologics: Targets Therapy. 2019;13:33.
   PubMed Web of Science ®Google Scholar
• Montalban X, Hauser SL, Kappos L, et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med. 2017;376:209–220.
   PubMed Web of Science ®Google Scholar
• Johansen A, Christensen SJ, Scheie D, et al. Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies: systematic review. Neurology. 2019;92:663–674.
   PubMed Web of Science ®Google Scholar
• Marhelava K, Pilch Z, Bajor M, et al. Targeting negative and positive immune checkpoints with monoclonal antibodies in therapy of cancer. Cancers. 2019;11:1756.
   Web of Science ®Google Scholar
• Yu X, Huang X, Chen X, et al. Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy. MAbs. 2019;11 Taylor & Francis:1139–1148.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Xu J, Gu X, et al. Immune checkpoint targeting TIGIT in hepatocellular carcinoma. Am J Transl Res. 2020;12:3212.
   Web of Science ®Google Scholar
• de Vries DH, Matzaraki V, Bakker OB, et al. Integrating GWAS with bulk and single-cell RNA-sequencing reveals a role for LY86 in the anti-Candida host response. PLoS Pathog. 2020;16:e1008408.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Dai Z, Locasale JW. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat Commun. 2019;10:1–12.
   Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
   PubMed Web of Science ®Google Scholar
• Zhang X, Feng H, Li Z, et al. Application of weighted gene co-expression network analysis to identify key modules and hub genes in oral squamous cell carcinoma tumorigenesis. Onco Targets Ther. 2018;11:6001.
   PubMed Web of Science ®Google Scholar
• Liao Y, Wang Y, Cheng M, et al. Weighted gene coexpression network analysis of features that control cancer stem cells reveals prognostic biomarkers in lung adenocarcinoma. Front Genet. 2020;11:311.
   PubMed Web of Science ®Google Scholar
• Deng W, Ma Y, Su Z, et al. Single-cell RNA-sequencing analyses identify heterogeneity of CD8+ T cell subpopulations and novel therapy targets in melanoma. Mol Therapy-Oncolytics. 2021;20:105–118.
   Web of Science ®Google Scholar
• Danion F, Aimanianda V, Bayry J, et al. Aspergillus fumigatus infection in humans With STAT3-deficiency Is associated with defective interferon-gamma and Th17 responses. Front Immunol. 2020;11:38.
   Web of Science ®Google Scholar
• Dutta O, Espinosa V, Wang K, et al. Dectin-1 promotes type I and III interferon expression to support optimal antifungal immunity in the lung. Front Cell Infect Microbiol. 2020;10:321.
   Web of Science ®Google Scholar
• Moyes DL, Murciano C, Runglall M, et al. Candida albicans yeast and hyphae are discriminated by MAPK signaling in vaginal epithelial cells. PloS one. 2011;6:e26580.
   PubMed Web of Science ®Google Scholar
• Böhringer M, Pohlers S, Schulze S, et al. Candida albicans infection leads to barrier breakdown and a MAPK/NF-κB mediated stress response in the intestinal epithelial cell line C2BBe1. Cell Microbiol. 2016;18:889–904.
   PubMed Web of Science ®Google Scholar
• Wolters TLC, Netea MG, Hermus ARMM, et al. IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK. J Mol Endocrinol. 2017;59:129–139.
   Web of Science ®Google Scholar
• Liu J, Geng F, Sun H, et al. Candida albicans induces TLR2/MyD88/NF-κB signaling and inflammation in oral lichen planus-derived keratinocytes. The J Infection Developing Countries. 2018;12:780–786.
   Web of Science ®Google Scholar
• Miró MS, Rodríguez E, Vigezzi C, et al. Contribution of TLR2 pathway in the pathogenesis of vulvovaginal candidiasis. Pathog Dis. 2017;75:ftx096.
   Google Scholar
• Liu X, Gao N, Dong C, et al. Flagellin-induced expression of CXCL10 mediates direct fungal killing and recruitment of NK cells to the cornea in response to Candida albicans infection. Eur J Immunol. 2014;44:2667–2679.
   PubMed Web of Science ®Google Scholar
• Wasiuk A, Testa J, Weidlick J, et al. CD27-mediated regulatory T cell depletion and effector T cell costimulation both contribute to antitumor efficacy. The J Immunol. 2017;199:4110–4123.
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Fournier B, Cordeiro DJ, et al. Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells. J Exp Med. 2019;216:2800–2818.
   PubMed Web of Science ®Google Scholar
• Gomes-Silva D, Atilla E, Atilla PA, et al. CD7 CAR T cells for the therapy of acute myeloid leukemia. Mol Ther. 2019;27:272–280.
   PubMed Web of Science ®Google Scholar
• Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6:1245–1252.
   PubMed Web of Science ®Google Scholar
• Chiba S, Baghdadi M, Akiba H, et al. Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol. 2012;13:832–842.
   PubMed Web of Science ®Google Scholar
• Huang Y-H, Zhu C, Kondo Y, et al. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature. 2015;517:386–390.
   PubMed Web of Science ®Google Scholar
• Long L, Zhang X, Chen F, et al. The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy. Genes Cancer. 2018;9:176.
   PubMedGoogle Scholar
• Lou J, Li X, Huang W, et al. SNX10 promotes phagosome maturation in macrophages and protects mice against Listeria monocytogenes infection. Oncotarget. 2017;8:53935.
   Google Scholar
• De Luca A, Carvalho A, Cunha C, et al. IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLoS Pathog. 2013;9:e1003486.
   PubMed Web of Science ®Google Scholar
• Sam QH, Yew WS, Seneviratne CJ, et al. Immunomodulation as therapy for fungal infection: are we closer? Front Microbiol. 2018;9:1612.
   Web of Science ®Google Scholar
• Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: a review. Semin Cancer Biol. 2020;64 Elsevier:93–101.
   PubMed Web of Science ®Google Scholar
• Abers MS, Lionakis MS, Kontoyiannis DP. Checkpoint inhibition and infectious diseases: a good thing? Trends Mol Med. 2019;25:1080–1093.
   Web of Science ®Google Scholar
• Wurster S, Robinson P, Albert ND, et al. Protective activity of programmed cell death protein 1 blockade and synergy with caspofungin in a murine invasive pulmonary aspergillosis model. J Infect Dis. 2020;222:989–994.
   Web of Science ®Google Scholar
• Stephen-Victor E, Karnam A, Fontaine T, et al. Aspergillus fumigatus cell wall α-(1, 3)-glucan stimulates regulatory T-cell polarization by inducing PD-L1 expression on human dendritic cells. J Infect Dis. 2017;216:1281–1294.
   PubMed Web of Science ®Google Scholar
• Quintin J, Saeed S, Martens JH, et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe. 2012;12:223–232.
   PubMed Web of Science ®Google Scholar
• Kim HS, Choi EH, Khan J, et al. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun. 2005;73:3714–3724.
   PubMed Web of Science ®Google Scholar
• Thompson A, Davies LC, Liao C-T, et al. The protective effect of inflammatory monocytes during systemic C. albicans infection is dependent on collaboration between C-type lectin-like receptors. PLoS Pathog. 2019;15:e1007850.
   Web of Science ®Google Scholar
• Halder LD, Abdelfatah MA, Jo EA, et al. Factor H binds to extracellular DNA traps released from human blood monocytes in response to Candida albicans. Front Immunol. 2017;7:671.
   Web of Science ®Google Scholar
• Hernández-Santos N, Huppler AR, Peterson AC, et al. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 2013;6:900–910.
   Web of Science ®Google Scholar
• Lindell DM, Moore TA, McDonald RA, et al. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. The J Immunol. 2005;174:7920–7928.
   Web of Science ®Google Scholar
• Ndhlovu LC, Lopez-Vergès S, Barbour JD, et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood, The J Am Soc Hematol. 2012;119:3734–3743.
   Google Scholar
• Andrews LP, Marciscano AE, Drake CG, et al. LAG 3 (CD 223) as a cancer immunotherapy target. Immunol Rev. 2017;276:80–96.
   PubMed Web of Science ®Google Scholar
• Goldberg MV, Drake CG. LAG-3 in cancer immunotherapy. Curr Top Microbiol Immunol. 2011;344:269–278.
   PubMed Web of Science ®Google Scholar